Inclusion criteria, exclusion criteria and study summary
All patients within 6 months of a new diagnosis of MF/SS
Patients diagnosed with MF/SS more than 6 months prior to assessment. Patients unable to give informed consent.
A study of prognostic factors in cutaneous lymphoma with the aim of developing a prognostic index to identify high risk patients